Controversies and focus on surgical treatment of pancreatic cancer
10.3760/cma.j.issn.1673-9752.2009.04.005
- VernacularTitle:胰腺癌外科治疗的热点与争论
- Author:
Bei SUN
;
Rui KONG
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Surgical treat-ment;
Adjuvant therapy
- From:
Chinese Journal of Digestive Surgery
2009;8(4):254-257
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a common disease with a poor prognosis. Despite recent advance in the field of diagnos-tic technique, surgical resection and adjuvant therapy for pan-creatic cancer, the overall 5-year survival rate is still less than 5%. This is due to its aggressive growth behavior, early local invasion and metastasis, and resistance to chemotherapy and radiation therapy. Surgical treatment is still regard as the only chance for curing pancreatic cancer. Many new strategies in the surgical treatment of pancreatic cancer, including extended lymphadeneetomy, vascular resection, the use of laparoscopy, surgery for metastastic or recurrent disease, and neoadjuvant therapy, are currently under debate. In this review, we discuss the current status of surgical treatment for pancreatic cancer, and highlight the controversies and focus.
